HOUSTON--(BUSINESS WIRE)--Stem Cell Innovations, Inc. (OTCBB: SCLL) today announced Ian Lyons, Ph.D., has been appointed Chief Scientific Officer, U.S. Dr. Lyons joins Helmuth van Es, Ph.D., Chief Scientific Officer, Europe, as co-leader of Stem Cell Innovation’s scientific programs. Dr. Lyons helped develop and characterize several of the human embryonic stem cell lines that are on the list approved for federally funded research in the U.S.
